Lincoln National Corp’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-15,642
Closed -$916K – 563
2024
Q1
$916K Sell
15,642
-12,287
-44% -$694K 0.01% 542
2023
Q4
$1.51M Sell
27,929
-39,687
-59% -$1.94M 0.03% 354
2023
Q3
$3.28M Buy
67,616
+1,636
+2% +$87K 0.07% 173
2023
Q2
$3.73M Sell
65,980
-2,044
-3% -$113K 0.07% 165
2023
Q1
$3.67M Buy
68,024
+662
+1% +$35.2K 0.08% 156
2022
Q4
$3.54M Buy
67,362
+4,365
+7% +$222K 0.08% 147
2022
Q3
$2.97M Buy
62,997
+858
+1% +$44.5K 0.07% 152
2022
Q2
$3.13M Sell
62,139
-31,114
-33% -$1.7M 0.07% 141
2022
Q1
$5.68M Buy
93,253
+3,652
+4% +$218K 0.12% 101
2021
Q4
$5.9M Buy
89,601
+1,021
+1% +$65.4K 0.12% 99
2021
Q3
$5.56M Buy
88,580
+8,348
+10% +$533K 0.12% 89
2021
Q2
$4.83M Buy
80,232
+786
+1% +$45.5K 0.1% 100
2021
Q1
$4.37M Buy
79,446
+9,804
+14% +$544K 0.11% 102
2020
Q4
$3.8M Sell
69,642
-1,884
-3% -$98.5K 0.1% 110
2020
Q3
$3.57M Buy
71,526
+6,624
+10% +$321K 0.11% 104
2020
Q2
$2.86M Buy
64,902
+15,684
+32% +$670K 0.09% 115
2020
Q1
$1.85M Buy
49,218
+12,630
+35% +$532K 0.07% 143
2019
Q4
$1.61M Buy
36,588
+1,002
+3% +$42.1K 0.05% 178
2019
Q3
$1.47M Buy
35,586
+29,952
+532% +$1.23M 0.05% 164
2019
Q2
$226K Buy
5,634
+6
+0.1% +$227 0.01% 497
2019
Q1
$217K Buy
+5,628
New +$204K 0.01% 461
2018
Q4
– Sell
-8,322
Closed -$316K – 498
2018
Q3
$316K Buy
8,322
+1,956
+31% +$69.5K 0.01% 352
2018
Q2
$213K Buy
+6,366
New +$207K 0.01% 445
2018
Q1
– Sell
-11,532
Closed -$333K – 553
2017
Q4
$333K Buy
+11,532
New +$333K 0.01% 464

Other funds holding IHI

Lincoln National Corp's IHI Position: Q2 2024 in Review

Lincoln National Corp sold out of iShares US Medical Devices ETF (IHI) in Q2 2024, closing a stake of 15,642 shares — an estimated $916K sold.

Lincoln National Corp first reported a position in IHI in Q4 2017 and held it in 24 quarters. The position peaked at $5.9M in Q4 2021. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2024.

  • Lincoln National Corp reported no remaining iShares US Medical Devices ETF position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 15,642 iShares US Medical Devices ETF shares in Q2 2024, an estimated $916K.
  • Lincoln National Corp first reported a position in iShares US Medical Devices ETF in Q4 2017 and held it in 24 quarters.
  • Lincoln National Corp's iShares US Medical Devices ETF position peaked at $5.9M in Q4 2021.
  • 546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.